At close: December 20 at 4:00:00 PM EST
After hours: 7:55:20 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ANISH BHATNAGAR Chief Executive Officer | Sale | Oct 1, 2024 | 719,553 |
| BIR DAWN CARTER Director | Stock Award(Grant) | Aug 15, 2024 | 13,000 |
| HIRANO PATRICIA C Officer | Sale | Oct 1, 2024 | 108,932 |
| HUANG MICHAEL F Officer | Stock Award(Grant) | Jul 17, 2024 | 35,000 |
| MACKANESS JAMES H Chief Financial Officer | Sale | Oct 1, 2024 | 119,172 |
| MANNING MEREDITH S. Officer | Stock Award(Grant) | Jul 17, 2024 | 40,000 |
| SINCLAIR ANDREW Director | Stock Award(Grant) | Jun 6, 2024 | 6,500 |
| VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 29, 2024 | -- |
| VOLCK BIRGITTE Director | Stock Award(Grant) | Jun 6, 2024 | 13,545 |
| YEN KRISTEN Officer | Sale | Oct 1, 2024 | 81,465 |
Related Tickers
RYTM Rhythm Pharmaceuticals, Inc.
56.12
+1.15%
ANNX Annexon, Inc.
5.23
+0.19%
PRAX Praxis Precision Medicines, Inc.
76.52
+5.05%
SVRA Savara Inc.
3.2300
0.00%
VRNA Verona Pharma plc
42.02
+1.94%
ACLX Arcellx, Inc.
75.54
+0.44%
SYRE Spyre Therapeutics, Inc.
23.86
+3.16%
FHTX Foghorn Therapeutics Inc.
5.14
+3.21%
LRMR Larimar Therapeutics, Inc.
4.0100
+0.75%
RARE Ultragenyx Pharmaceutical Inc.
44.22
+1.73%